Sen. John Hoeven (R-ND) sold $100K-$250K of ABBV stock

John Hoeven, U.S. Senator (R-ND), disclosed a sale of AbbVie Inc. (NYSE) (ABBV) stock worth $100K-$250K in a STOCK Act filing on Oct 22, 2014.

The trade happened on Sep 29, 2014, 23 days before it was made public.

ABBV has moved +403.2% since the trade date, from $58.52 to $294.45 (Nov 12, 2026 close).